Show simple item record

dc.contributor.authorKirkhus, Lene
dc.contributor.authorSaltyte Benth, Jurate
dc.contributor.authorGrønberg, Bjørn Henning
dc.contributor.authorHjermstad, Marianne Jensen
dc.contributor.authorRostoft, Siri
dc.contributor.authorHarneshaug, Magnus
dc.contributor.authorSelbæk, Geir
dc.contributor.authorWyller, Torgeir Bruun
dc.contributor.authorJordhøy, Marit Slaaen
dc.date.accessioned2019-12-27T07:54:35Z
dc.date.available2019-12-27T07:54:35Z
dc.date.created2019-02-06T15:02:33Z
dc.date.issued2019
dc.identifier.citationPalliative Medicine. 2019, 33 (3), 312-322.nb_NO
dc.identifier.issn0269-2163
dc.identifier.urihttp://hdl.handle.net/11250/2634418
dc.description.abstractBackground: Maintaining quality of life including physical functioning is highly prioritized among older cancer patients. Geriatric assessment is a recommended approach to identify patients with increased vulnerability to stressors (frailty). How frailty affects quality of life and physical functioning in older cancer patients has scarcely been investigated. Aim: Focusing on physical functioning and global quality of life, we investigated whether frailty identified by a geriatric assessment was associated with higher risk of quality-of-life deterioration during cancer treatment and follow-up. Design: Prospective, observational study. Patients were classified as frail or non-frail by a modified geriatric assessment. Quality of life was measured using the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire at inclusion, 2, 4, 6 and 12 months. Setting: Eight Norwegian outpatient cancer clinics. Participants: Patients ⩾70 years with solid tumours referred for palliative or curative systemic medical cancer treatment. Results: Among 288 patients included, 140 (49%) were frail and 148 (51%) non-frail. Frail patients consistently reported poorer scores on all functioning and symptom scales. Independent of age, gender and major cancer-related factors, frail patients had significantly poorer physical functioning and global quality of life during follow-up, and opposed to non-frail patients they had both a clinically and statistically significant decline in physical functioning from baseline until 12 months. Conclusions: Geriatric assessment identifies frail patients with increased risk of physical decline, poor functioning and high symptom burden during and following cancer treatment. Frail patients should therefore receive early supportive or palliative care.nb_NO
dc.language.isoengnb_NO
dc.publisherSage Publicationsnb_NO
dc.rightsNavngivelse-Ikkekommersiell 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/deed.no*
dc.titleFrailty identified by geriatric assessment is associated with poor functioning, high symptom burden and increased risk of physical decline in older cancer patients: Prospective observational studynb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.source.pagenumber312-322nb_NO
dc.source.volume33nb_NO
dc.source.journalPalliative Medicinenb_NO
dc.source.issue3nb_NO
dc.identifier.doi10.1177/0269216319825972
dc.identifier.cristin1674133
dc.description.localcodeOpen Access CC-BY-NCnb_NO
cristin.unitcode194,65,15,0
cristin.unitcode1920,12,0,0
cristin.unitnameInstitutt for klinisk og molekylær medisin
cristin.unitnameKreftklinikken
cristin.ispublishedtrue
cristin.fulltextpostprint
cristin.qualitycode1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse-Ikkekommersiell 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse-Ikkekommersiell 4.0 Internasjonal